Innovative Medicines Initiative is on the way to be fully operative by the beginning of 2008

In May the European Commission presented the Innovative Medicines Initiative (IMI), one of two Joint Technology Initiatives, to the Competitiveness Council.
Organised as a public private partnership between the European Commission and European Pharmaceutical Companies, IMI will invest € 2 billion to support the development of new tools, methods and knowledge to overcome major bottlenecks in the drug discovery and development process.

By Ferran Sanz

The Collegium Helveticum Zürich

Founded in 1997 by the ETH Zuerich, the Collegium Helveticum pursues interdisciplinary and transdisciplinary research with the objective of promoting a more in-depth discourse of natural and technical sciences with humanities and social sciences.

By Gerd Folkers

Health topics in the second call of the FP7

In this edition of the EFMC Newsletter, we will recall the Health topics in the second call of the FP7 (http://cordis.europa.eu/fp7/cooperation/health_en.html) that may require medicinal chemistry efforts and also alert on a call from the European Science Foundation aiming at funding Research Networking Programmes (http://www.esf.org/activities/research-networking-programmes.html).

By Jordi Mestres

At the annual meeting, this year held in Portoroz, the council of EFMC unanimously accepted the application of the Section for Pharmaceutical/Medicinal Chemistry, German Pharmaceutical Society, and the Medicinal Chemistry Group, Portuguese Chemical Society, to become Member Societies of EFMC.

By Gerhard Ecker